Angstrom AI leverages GenAI-based molecular simulations to replace wet lab experiments in pre-clinical drug development.
Ongstrom AI has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2024.
Ongstrom AI's investors include Y Combinator, Pioneer Fund, Rebel Fund, Unpopular Ventures.
Ongstrom AI is headquartered in San Francisco, United States.
Angstrom AI leverages GenAI-based molecular simulations to replace wet lab experiments in pre-clinical drug development.
Ongstrom AI is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ongstrom AI — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/ongstrom-ai. Accessed July 20, 2026.
VCBacked. (2024). Ongstrom AI — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/ongstrom-ai
{{cite web |title=Ongstrom AI — Funding & Investors |url=https://www.vcbacked.co/company/ongstrom-ai |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated